The Latest Breaking News from Pfizer

A renewed focus on health and wellness has been a boon to the reputations of health care companies, according to new rankings from the annual Axios/Harris Poll 100.

Reuters Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims

Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday.

Pfizer says it will provide nearly two dozen products at not-for-profit prices in some of the world’s poorest countries

The Dow Jones rose despite negative economic data. Tech stocks suffered amid worrying guidance from Snap. Apple stock and Amazon stock fell.

Germany's vaccine advisory panel on Tuesday said one COVID-19 shot was enough for healthy five- to 11-year-olds because most of them had already undergone an infection, maintaining its cautious approach.

Pfizer Inc (NYSE:PFE) has announced detailed results from two pivotal studies from ELEVATE UC Phase 3 program evaluating etrasimod for active ulcerative colitis (UC).  The drug, etrasimod, was Pfizer's key asset in its $6.7 billion deal for Arena Pharmaceuticals last year.  UC is an inflammatory bowel disease that affects around 3.8 million people in North…

While the AZ./Oxford vaccine has all but vanished from richer countries, it has continued to be rolled out elsewhere

Pfizer's nearly $7 billion takeover of Arena paid off Tuesday in ulcerative colitis treatment. The results could send Pfizer stock higher.